We are live on ! Find out more
OPTR

OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR

Delisted

OPTR was delisted on the 23rd of October, 2013.

Back to rankings

103 hedge funds and large institutions have $642M invested in OPTIMER PHARMACEUTICALS, INC. COM STK in 2013 Q2 according to their latest regulatory filings, with 103 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more call options, than puts

Call options by funds: $20.5M | Put options by funds: $16.4M

Holders
103
Holders Change
+103
Holders Change %
–
% of All Funds
3.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
103
Increased
–
Reduced
–
Closed
–
Calls
$20.5M
Puts
$16.4M
Net Calls
+$4.08M
Net Calls Change
+$4.08M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CII
26
CR Intrinsic Investors
Connecticut
$4.55M +$4.58M +314,718 New
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
$4.28M +$4.31M +295,876 New
TAL
28
TIG Advisors LLC
New York
$3.9M +$3.92M +269,265 New
MWVC
29
Morgens Waterfall Vintiadis & Co
New York
$3.69M +$3.71M +255,000 New
Millennium Management
30
Millennium Management
New York
$3.67M +$3.69M +253,523 New
Bank of New York Mellon
31
Bank of New York Mellon
New York
$3.5M +$3.52M +241,753 New
Allianz Asset Management
32
Allianz Asset Management
Germany
$3.29M +$3.31M +227,050 New
TCIM
33
TIAA CREF Investment Management
New York
$3.25M +$3.27M +224,714 New
Geode Capital Management
34
Geode Capital Management
Massachusetts
$2.94M +$2.95M +202,805 New
OAM
35
Oxford Asset Management
United Kingdom
$2.76M +$2.78M +190,603 New
SG Americas Securities
36
SG Americas Securities
New York
$2.69M +$2.71M +185,764 New
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$2.68M +$2.69M +184,931 New
LCM
38
LionEye Capital Management
New York
$2.57M +$2.59M +177,799 New
USAA
39
United Services Automobile Association
Texas
$2.52M +$2.54M +174,348 New
CI
40
Cowen Inc
New York
$2.14M +$2.15M +147,648 New
CS
41
Credit Suisse
Switzerland
$2.1M +$2.12M +145,499 New
BIM
42
BlackRock Investment Management
Delaware
$1.86M +$1.87M +128,717 New
Charles Schwab
43
Charles Schwab
California
$1.72M +$1.73M +118,623 New
Group One Trading
44
Group One Trading
Illinois
$1.67M +$1.68M +115,096 New
WMSA
45
Weiss Multi-Strategy Advisers
New York
$1.59M +$1.6M +110,000 New
BCM
46
BBT Capital Management
Texas
$1.52M +$1.53M +105,000 New
SCA
47
SAC Capital Advisors
Connecticut
$1.48M +$1.49M +102,560 New
SC
48
Sophrosyne Capital
New York
$1.45M +$1.46M +100,500 New
Norges Bank
49
Norges Bank
Norway
$1.39M +$1.4M +95,877 New
TD Asset Management
50
TD Asset Management
Ontario, Canada
$1.24M +$1.24M +85,400 New
1
2
3 4 5

OPTR Hedge Fund Activity: Q2 2013 in Review

103 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) for Q2 2013, worth a combined $642M.

Buyers outnumbered sellers: 103 funds opened new OPTR positions and 0 closed out — a net gain of 103 holders — while 0 added to existing stakes and 0 trimmed.

  • 103 institutional investors held OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $642M of OPTIMER PHARMACEUTICALS, INC. COM STK stock for Q2 2013.
  • 103 funds opened new OPTIMER PHARMACEUTICALS, INC. COM STK positions in Q2 2013 and 0 closed out, a net change of +103 holders.

Based on aggregated 13F filings for Q2 2013.